Gujarat Themis Biosyn Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 12, 2025
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Themis Biosyn Limited has announced that its 44th Annual General Meeting will be held on Friday, 12th September 2025 at 12:00 noon at the registered office of Themis Medicare Limited in Vapi, Gujarat. The meeting will cover ordinary business such as adoption of audited FY25 financial statements, re-appointment of Dr. Dinesh S. Patel as a director, and declaration of dividend. Key special business items include the appointment and re-designation of Dr. Sachin D. Patel as Managing Director for 5 years from 1st July 2025, appointment of a new Secretarial Auditor (M/s. KRS AND Co.) for 5 years, and payment of commission of Rs. 66 lakh each to the Chairman and Dr. Sachin Patel. From the Chairman's message, the company reported FY25 revenue of Rs. 150.8 crores, EBITDA of Rs. 68.8 crores, and profit after tax of Rs. 48.8 crores, with progress on a new R&D facility, a dedicated API block entering validation, and additional fermentation capacity under construction.
Shareholders should note the record date of 5th September 2025 for dividend eligibility, and the e-voting window from 9th to 11th September 2025. The strong FY25 profitability and ongoing capex on R&D, API manufacturing, and fermentation capacity point to a growth-oriented outlook, while leadership changes (new MD, CFO, and several independent directors) signal a transition phase that investors may want to monitor.